Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program

Derrick H. W. Siu, Frank P. Y. Lin, David M. Thomas, Subotheni Thavaneswaran, David Espinoza, Sarah Chinchen, Mandy L. Ballinger, R. John Simes, Chee Khoon Lee · 2026

Read Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program by Derrick H. W. Siu, Frank P. Y. Lin, David M. Thomas, Subotheni Thavaneswaran, David Espinoza, Sarah Chinchen, Mandy L. Ballinger, R. John Simes, Chee Khoon Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13390511.txt.

Description

Derrick H W Siu and colleagues pool, in 2026, early cancer trial data to test a simple within-patient yardstick of benefit. The time-to-progression ratio compares how long a new treatment holds disease against how long the patient's immediately prior therapy held it.

Drawing on eight phase two trials from an Australian molecular screening programme, the analysis covered 246 evaluable participants. It related the ratio to response rates and overall survival. Landmark checks were used to reduce timing bias. Median control times on prior and study therapy are reported for context. Trial designers gain evidence on whether this ratio still predicts who benefits in the era of immune checkpoint drugs.

Catalog record

CREATORDerrick H. W. Siu, Frank P. Y. Lin, David M. Thomas, Subotheni Thavaneswaran, David Espinoza, Sarah Chinchen, Mandy L. Ballinger, R. John Simes, Chee Khoon Lee
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE36944
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13390511

Browse the full library · About the Tower of Babel